Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Screening potential allergy vaccine components
NL-OMON24623Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jan 2020
- Countries
- 1
01
Overview
Open-label trial in allergy, allergic rhinitis (AR) and food allergy (3 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: Successful generation of sufficient monocyte-derived dendritic cells and Blood sample acquisition for monocyte isolation. Planned start Jan 2020; status: not yet recruiting.
02
Conditions
allergyallergic rhinitis (AR)food allergy
Beyond the preview
Go deeper on NL-OMON24623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24623.